Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

  1. Orkin, C.
  2. Molina, J.-M.
  3. Negredo, E.
  4. Arribas, J.R.
  5. Gathe, J.
  6. Eron, J.J.
  7. Van Landuyt, E.
  8. Lathouwers, E.
  9. Hufkens, V.
  10. Petrovic, R.
  11. Vanveggel, S.
  12. Opsomer, M.
  13. Ajana, F.
  14. Arribas, J.R.
  15. Bailey, J.
  16. Benson, P.
  17. Berenguer, J.
  18. Bhatti, L.
  19. Blaxhult, A.
  20. Brar, I.
  21. Bredeek, U.F.
  22. Brinson, C.
  23. Brunetta, J.
  24. Casado, J.
  25. Clarke, A.
  26. Conway, B.
  27. Cotte, L.
  28. Crofoot, G.
  29. Cunningham, D.
  30. de Vente, J.
  31. De Wit, S.
  32. DeJesus, E.
  33. Dietz, C.
  34. Dretler, R.
  35. Eron, J.
  36. Fehr, J.
  37. Felizarta, F.
  38. Fichtenbaum, C.
  39. Flamholc, L.
  40. Florence, E.
  41. Galindo, M.J.
  42. Gallant, J.
  43. Gasiorowski, J.
  44. Gatell, J.M.
  45. Gazzard, B.G.
  46. Girard, P.-M.
  47. Gisslèn, M.
  48. Gutierrez, F.
  49. Gutierrez, M.D.M.
  50. Hagins, D.
  51. Halota, W.
  52. Henn, S.
  53. Henry, W.K.
  54. Horban, A.
  55. Huhn, G.
  56. Iribarren, J.A.
  57. Jain, M.
  58. Johnson, M.A.
  59. Katlama, C.
  60. Klein, M.
  61. Knobel, H.
  62. Lucasti, C.
  63. Martorell, C.
  64. McDonald, C.
  65. Mills, A.
  66. Molina, J.-M.
  67. Morales-Ramirez, J.
  68. Mounzer, K.
  69. Moutschen, M.
  70. Murphy, D.
  71. Nahass, R.
  72. Negredo, E.
  73. Olivet, H.
  74. Osiyemi, O.
  75. Perez-Valero, I.
  76. Piekarska, A.
  77. Pineda, J.A.
  78. Podzamczer, D.
  79. Poizot-Martin, I.
  80. Portilla Sogorb, J.
  81. Post, F.
  82. Prelutsky, D.
  83. Pulido, F.
  84. Rachlis, A.
  85. Raffi, F.
  86. Ramgopal, M.
  87. Rashbaum, B.
  88. Rauch, A.
  89. Rey, D.
  90. Reynes, J.
  91. Ricart, C.
  92. Richmond, G.
  93. Rivero, A.
  94. Ruane, P.
  95. Gil, I.S.
  96. Scarsella, A.
  97. Scribner, A.
  98. Shafran, S.
  99. Shalit, P.
  100. Shamblaw, D.
  101. Slim, J.
  102. Stoeckle, M.
  103. Tashima, K.
  104. Teicher, E.
  105. Thalme, A.
  106. Ustianowski, A.
  107. Van Wijngaerden, E.
  108. Vandekerckhove, L.
  109. Vandercam, B.
  110. Voskuhl, G.
  111. Walmsley, S.
  112. Ward, D.
  113. Waters, L.
  114. Wilkin, A.
  115. Witor, A.
  116. Yazdanpanah, Y.
  117. Show all authors +
Journal:
The Lancet HIV

ISSN: 2352-3018

Year of publication: 2018

Volume: 5

Issue: 1

Pages: e23-e34

Type: Article

DOI: 10.1016/S2352-3018(17)30179-0 GOOGLE SCHOLAR

Sustainable development goals